System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Nadia M Hamdy is an expert in Biochemistry at Ain Shams University (Egypt). As of October 2026, ScienceLeadR ranks Nadia M Hamdy in the top 1% of experts in Egypt for Gastrointestinal Neoplasms. Nadia M Hamdy has authored 166 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 699 (community average: 125). How the SLR is computed.

LeadR Profile

Nadia M Hamdy Ain Shams University Egypt
699 ScienceLeadR Reputation 699

Unlock

Register Login
Network Map

Biochemistry

Subspecialties: Public Health - Oncology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Prof. Dr. Nadia M. HamdyProf. of Clinical Pharmaceutical Biochemistry and Molecular Biology, Faculty of Pharmacy, Ain Shams UniversityNadia_hamdy@pharma.asu.edu.eg Dept. Head (Feb. 2013-July 2015 & Sept. 2019- Sept. 2023) GBD Senior Collaboratorhttps://www.asu.edu.eg/staffPortal/en/staffProfile/1010

Prof. Hamdy is a member in projects funded by NIH/AHA, European PRIMA, Erasmus+, ASRT-Egypt, STDF-Egypt, STDF-Germany, Higher Ministry of Education Egypt, “HME & Scientific Research”, ASU since 2004-till-now. Dr. Nadia has 140+ publications, 2 edited books and 14+ book chapters, with Scopus h index 51 and 50 Masters’ and Ph.D. supervised students.

Prof. Hamdy is one of the world 2% influencing Scientists, she earned Obada International Prize for the Life time achievement Scientists and 2 International BSI 2025 conference by Harvard University, honorary awards, Ain Shams University Appreciation award in Technological Sciences for the year 2024, the ASRT State Award Dr Shawky el Hadad award in cancer for the year 2023, International “Wendy Harvan” Top Honorary Award & Certificate in February 2023, “Paola Sassone-Corsi” Top Award in February 2021, and ASU first “Best Scientific Project Research Topic” 2021 & Honored by Women Of Egypt (WOE) 2020 to 2023 yearly.

Dr. Nadia is an Ambassador of the EACR and Bentham Publisher. She is a member of the Biochemical Society & FEBS, IFCC, ISPE Mena Chapter, ESMO, AAAS, and more.

Dr. Hamdy is a fellow of the GBD, MHE Egypt, ASU, ASRT-Egypt.

Prof. Nadia is a member of the editorial board of 10 Scopus (Q1 & Q2) journals and reviewer for hundereds of international and regional grants, awards, and scientific journals.


Organizations

Career arc: 1999 - 2026
Source: PubMed

Ain Shams University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 166

Citations

Citations: 5 908 1st author: 32 Last author: 44 Unique author: 1

Main journals

Int J Mol Sci 11
Lancet 11
Pathol Res Pract 8
Subcell Biochem 8
Int J Biol Macromol 5

Best Journals

Lancet 11
Nat Med 4
Lancet Neurol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Burden of cancer in Africa, 1990-2023: a systematic analysis from the Global Burden of Disease Study 2023.
PMID 42743938 — mortality, incidence, neoplasms, uncertainty, global burden of disease, aged, adolescent, sex, risk factors, accounting, cost of illness		Lancet Oncol Top journal20260
Autism spectrum disorder burden across 798 locations, 1990-2023: frontier and inequality mapping in the context of child injury prevention and safety promotion.
PMID 42780228 — autism spectrum disorder, safety, incidence, public health, autistic disorder, child		Front Public Health20260
Anxiety and depressive disorders in adolescent injury prevention and safety promotion: frontier and inequality mapping across 953 locations.
PMID 42683351 — safety, public health, depressive disorder, adolescent, cost of illness, mental health		Front Public Health20260
Can Carica papaya Serve as an Adjunct to Semaglutide in Mitigating Diabetes-Induced Testicular Injury Through Modulation of Oxidative Stress, Inflammation, Apoptosis, and the miR-34c/miR-155-SIRT1/FOXO1 Axis? An Experimental and Chem-Bio-Informatics Study.
PMID 42589610 — diabetes mellitus, cells, tumor necrosis factor-alpha, stress, physiological, interleukin-6, cytochrome p-450 cyp2e1, informatics, caspase 3, oxidative stress, antioxidants, apoptosis, spermatozoa, sirtuin 1, semaglutide		Int J Mol Sci20260
Functional roles and clinical implications of pseudogenes signatures as emerging biomarkers in cancer.
PMID 42562996 — genes, neoplasms, biomarkers, pseudogenes		Discov Oncol20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 2

By status:

Completed 1
Not yet recruiting 1

By type:

Observational 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune Checkpoint Protein(s)
NCT06502249 — prodigiosin, lung, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, pioglitazone, protein s, therapeutics, immune checkpoint proteins		N/ANot yet recruiting2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS